OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 495
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 495
Showing 1-25 of 495 citing articles:
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
Do‐Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
NEJM Evidence (2022) Vol. 1, Iss. 8
Closed Access | Times Cited: 635
Do‐Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
NEJM Evidence (2022) Vol. 1, Iss. 8
Closed Access | Times Cited: 635
Lipid alterations in chronic liver disease and liver cancer
Bichitra Paul, Monika Lewińska, Jesper B. Andersen
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 189
Bichitra Paul, Monika Lewińska, Jesper B. Andersen
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 189
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 89
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 89
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression
Adrien Guillot, Marc Winkler, Milessa Silva Afonso, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 150-166
Closed Access | Times Cited: 54
Adrien Guillot, Marc Winkler, Milessa Silva Afonso, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 150-166
Closed Access | Times Cited: 54
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Zhaoliang Hu, Xushi Zhao, Zhonghua Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Zhaoliang Hu, Xushi Zhao, Zhonghua Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Potential Influence of Antifungal-drug Resistant Pathogens in Patients with Cholangiocarcinoma and the Application of Nanoparticle Mechanisms as Novel Antifungal and Anticancer Agents
Conrad Chibunna Achilonu, Tsepo Ramatla, Maleke Maleke, et al.
Current Clinical Microbiology Reports (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Conrad Chibunna Achilonu, Tsepo Ramatla, Maleke Maleke, et al.
Current Clinical Microbiology Reports (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
Shin‐Yi Chung, Yi‐Chen Yeh, Chien-Jung Huang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010173-e010173
Open Access | Times Cited: 1
Shin‐Yi Chung, Yi‐Chen Yeh, Chien-Jung Huang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010173-e010173
Open Access | Times Cited: 1
lncRNA PVT1: a novel oncogene in multiple cancers
Ruiming Li, Xia Wang, Chunming Zhu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 48
Ruiming Li, Xia Wang, Chunming Zhu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 48
JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis
Shan Lei, Wenpeng Cao, Zhirui Zeng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 39
Shan Lei, Wenpeng Cao, Zhirui Zeng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 39
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 38
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 38
Zhan‐Cheng Zeng, Qi Pan, Yu‐Meng Sun, et al.
EMBO Reports (2023) Vol. 24, Iss. 3
Open Access | Times Cited: 30
Immunobiology of cholangiocarcinoma
Jennifer L. Tomlinson, Juan W. Valle, Sumera I. Ilyas
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 867-875
Open Access | Times Cited: 30
Jennifer L. Tomlinson, Juan W. Valle, Sumera I. Ilyas
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 867-875
Open Access | Times Cited: 30
New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
Ezequiel Mauro, Joana Ferrer, Tamara Saurí, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1244-1244
Open Access | Times Cited: 25
Ezequiel Mauro, Joana Ferrer, Tamara Saurí, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1244-1244
Open Access | Times Cited: 25
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
Simon Rushbrook, Timothy J. Kendall, Yoh Zen, et al.
Gut (2023) Vol. 73, Iss. 1, pp. 16-46
Open Access | Times Cited: 25
Simon Rushbrook, Timothy J. Kendall, Yoh Zen, et al.
Gut (2023) Vol. 73, Iss. 1, pp. 16-46
Open Access | Times Cited: 25
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma
Jia‐Cheng Lu, Lei‐Lei Wu, Yining Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Jia‐Cheng Lu, Lei‐Lei Wu, Yining Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Advances in targeted therapy of cholangiocarcinoma
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
The scaffold of neutrophil extracellular traps promotes CCA progression and modulates angiogenesis via ITGAV/NFκB
Congyi Zhang, Dehai Wu, Bowen Dong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Congyi Zhang, Dehai Wu, Bowen Dong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer
Cheng‐Yu Tang, Yi‐Ting Lin, Yi‐Chen Yeh, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 1
Cheng‐Yu Tang, Yi‐Ting Lin, Yi‐Chen Yeh, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 1
Genomic Profiling of Biliary Tract Cancers: Comprehensive Assessment of Anatomic and Geographic Heterogeneity, Co‐Alterations and Outcomes
Diamantis I. Tsilimigras, Hunter Stecko, Demetrios Moris, et al.
Journal of Surgical Oncology (2025)
Open Access | Times Cited: 1
Diamantis I. Tsilimigras, Hunter Stecko, Demetrios Moris, et al.
Journal of Surgical Oncology (2025)
Open Access | Times Cited: 1
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer
Aburough Abegesah, Do-Youn Oh, KyoungSoo Lim, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Open Access | Times Cited: 1
Aburough Abegesah, Do-Youn Oh, KyoungSoo Lim, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Open Access | Times Cited: 1
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential
Yongfei Fan, Xinwei Li, Huihui Sun, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1224-1224
Open Access | Times Cited: 29
Yongfei Fan, Xinwei Li, Huihui Sun, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1224-1224
Open Access | Times Cited: 29
